Literature DB >> 1695985

Differential effect of GM-CSF and G-CSF in cyclic neutropenia.

M R Freund, S Luft, C Schöber, P Heussner, H Schrezenmaier, F Porzsolt, K Welte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1695985     DOI： 10.1016/0140-6736(90)91849-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 2.  Congenital neutropenia: diagnosis, molecular bases and patient management.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Nizar Mahlaoui; Christine Bellanné Chantelot
Journal:  Orphanet J Rare Dis       Date:  2011-05-19       Impact factor: 4.123

3.  Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis.

Authors:  M Katano; M Nakamura; T Matsuo; A Iyama; T Hisatsugu
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

5.  Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case report.

Authors:  L Oehler; E Reiter; J Friedl; E Kabrna; O A Haas; A Rosenkranz; K Lechner; K Geissler
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.